← FDA DRUG APPROVALS

FDA ANDA · ANDA086399

THEOLAIR

Sponsor: MEDICIS

APPLICATION
ANDA086399
TYPE
ANDA
ORIGINAL APPROVAL
1980-05-30
LATEST ACTION
1998-10-20
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

THEOLAIRDiscontinued
THEOPHYLLINE 250MG · TABLET · ORAL
THEOLAIRDiscontinued
THEOPHYLLINE 125MG · TABLET · ORAL

Approval history

1998-10-20Manufacturing (CMC) · Supplement 15AP
1998-01-20Manufacturing (CMC) · Supplement 14AP
1996-09-20Labeling · Supplement 13AP
1993-07-08Manufacturing (CMC) · Supplement 12AP
1990-09-18Labeling · Supplement 10AP
1984-06-22Manufacturing (CMC) · Supplement 5AP
1980-05-30OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →